Terug
Dagbereik
€ 136,47
€ 138,37
52-Weeksbereik
€ 93,37
€ 157,29
Volume
6.414.730
50D / 200D Gem.
€ 141,92
/
€ 123,02
Vorige Slotkoers
€ 137,34
Koershistorie
Financiële Trends
Sectorvergelijking
vs Healthcare sector mediaan (627 peers)
| Metriek | Aandeel | Sector Mediaan |
|---|---|---|
| P/E | 20,2 | 0,3 |
| P/B | 7,6 | 2,9 |
| ROE % | 40,6 | 3,7 |
| Net Margin % | 28,9 | 3,8 |
| Rev Growth 5Y % | 1,9 | 10,0 |
| D/E | 1,1 | 0,2 |
Koersdoel Analisten
Hold
€ 158,71
+14.9%
Low: € 105,00
High: € 180,00
Forward K/W
15,8
Forward WPA
€ 8,68
WPA Groei (sch.)
+0,0%
Omzet Sch.
30 B
Winstschattingen
| Periode | WPA Sch. | Omzet Sch. | Analisten |
|---|---|---|---|
| FY2030 |
€ 12,67
€ 12,21 – € 13,25
|
38 B | 6 |
| FY2029 |
€ 11,68
€ 11,26 – € 12,22
|
36 B | 6 |
| FY2028 |
€ 10,50
€ 8,62 – € 11,85
|
34 B | 8 |
Insider Trading Activity
Buy ratio (90d)
0.0%
20 transactions
| Date | Insider | Type | Shares | Price | Value |
|---|---|---|---|---|---|
| Mar 16, 2026 |
Mercier Johanna
Chief Comm & Corp Aff Officer
|
sell | 3.000 | € 144,23 | € 432.690 |
| Mar 16, 2026 |
Dickinson Andrew D
Chief Financial Officer
|
sell | 3.000 | € 144,23 | € 432.690 |
| Feb 27, 2026 |
Berger Dietmar
Chief Medical Officer
|
grant | 8.530 | — | — |
| Feb 27, 2026 |
Cain Wettan Keeley M
EVP Gen Counsel, Legal & Comp
|
grant | 470 | — | — |
| Jan 20, 2026 |
Bluestone Jeffrey
Director
|
other | 10.000 | € 67,45 | — |
| Jan 20, 2026 |
Bluestone Jeffrey
Director
|
sell | 5.000 | € 123,50 | € 617.500 |
| Dec 29, 2025 |
O'Day Daniel Patrick
Chairman & CEO
|
sell | 10.000 | € 124,83 | € 1.248.272 |
| Dec 15, 2025 |
Dickinson Andrew D
Chief Financial Officer
|
sell | 3.000 | € 122,00 | € 366.000 |
| Nov 28, 2025 |
Bluestone Jeffrey
Director
|
other | 10.000 | € 64,92 | — |
| Nov 28, 2025 |
Bluestone Jeffrey
Director
|
sell | 5.000 | € 125,08 | € 625.400 |
| Nov 17, 2025 |
Dickinson Andrew D
Chief Financial Officer
|
sell | 2.500 | € 125,23 | € 313.075 |
| Oct 15, 2025 |
Dickinson Andrew D
Chief Financial Officer
|
sell | 2.500 | € 118,08 | € 295.200 |
| Sep 15, 2025 |
Mercier Johanna
Chief Commercial Officer
|
sell | 3.000 | € 113,57 | € 340.710 |
| Sep 10, 2025 |
Mercier Johanna
Chief Commercial Officer
|
other | 9.507 | — | — |
| Jul 15, 2025 |
Mercier Johanna
Chief Commercial Officer
|
sell | 3.000 | € 111,03 | € 333.090 |
| Jun 16, 2025 |
Dickinson Andrew D
Chief Financial Officer
|
sell | 2.500 | € 110,17 | € 275.425 |
| Jun 10, 2025 |
Telman Deborah H
EVP, Corporate Affairs & GC
|
other | 3.056 | — | — |
| Jun 10, 2025 |
Wilfong Diane E.
Interim Corp Controller & CAO
|
other | 2.180 | — | — |
| Jun 10, 2025 |
Dickinson Andrew D
Chief Financial Officer
|
other | 9.146 | — | — |
| May 15, 2025 |
Dickinson Andrew D
Chief Financial Officer
|
sell | 2.500 | € 99,82 | € 249.550 |
Belangrijkste Punten
Revenue grew 1,90% annually over 5 years — modest growth
Earnings grew 1672,92% over the past year
ROE of 40,57% indicates high profitability
Net margin of 28,90% shows strong profitability
Generating 9,46B in free cash flow
PEG of 0,01 suggests growth is underpriced
Groei
Revenue Growth (5Y)
1,90%
Revenue (1Y)2,40%
Earnings (1Y)1672,92%
FCF Growth (3Y)12,88%
Kwaliteit
Return on Equity
40,57%
ROIC18,77%
Net Margin28,90%
Op. Margin40,14%
Veiligheid
Debt / Equity
1,09
Current Ratio1,68
Interest Coverage11,54
Waardering
P/E Ratio
20,15
P/B Ratio7,58
EV/EBITDA15,95
Dividend Yield0,03%
All Fundamental Metrics
| Growth | |||
| Revenue Growth (1Y) | 2,40% | Revenue Growth (3Y) | 4,20% |
| Earnings Growth (1Y) | 1672,92% | Earnings Growth (3Y) | 22,56% |
| Revenue Growth (5Y) | 1,90% | Earnings Growth (5Y) | 8,13% |
| Profitability | |||
| Revenue (TTM) | 29,44B | Net Income (TTM) | 8,51B |
| ROE | 40,57% | ROA | 14,42% |
| Gross Margin | 86,69% | Operating Margin | 40,14% |
| Net Margin | 28,90% | Free Cash Flow (TTM) | 9,46B |
| ROIC | 18,77% | FCF Growth (3Y) | 12,88% |
| Safety | |||
| Debt / Equity | 1,09 | Current Ratio | 1,68 |
| Interest Coverage | 11,54 | Dividend Yield | 0,03% |
| Valuation | |||
| P/E Ratio | 20,15 | P/B Ratio | 7,58 |
| P/S Ratio | 5,82 | PEG Ratio | 0,01 |
| EV/EBITDA | 15,95 | Dividend Yield | 0,03% |
| Market Cap | 171,45B | Enterprise Value | 188,48B |
Income Statement
Annual, most recent first
| Metric | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|
| Revenue | 29,44B | 28,75B | 27,12B | 27,28B | 27,31B |
| Net Income | 8,51B | 480,00M | 5,67B | 4,59B | 6,23B |
| EPS (Diluted) | 6,78 | 0,38 | 4,50 | 3,64 | 4,93 |
| Gross Profit | 25,52B | 22,50B | 20,62B | 21,62B | 20,70B |
| Operating Income | 11,82B | 1,66B | 7,61B | 7,33B | 9,92B |
Balance Sheet
Annual, most recent first
| Metric | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|
| Total Assets | 59,02B | 59,00B | 62,13B | 63,17B | 67,95B |
| Total Liabilities | 36,41B | 39,75B | 39,38B | 41,96B | 46,89B |
| Shareholders' Equity | 22,62B | 19,33B | 22,83B | 21,24B | 21,07B |
| Total Debt | 24,59B | 26,71B | 24,99B | 25,23B | 26,70B |
| Cash & Equivalents | 7,56B | 9,99B | 6,09B | 5,41B | 5,34B |
| Current Assets | 19,89B | 19,17B | 16,09B | 14,44B | 14,77B |
| Current Liabilities | 11,81B | 12,00B | 11,28B | 11,24B | 11,61B |